Universe Pharmaceuticals (UPC) Debt to Equity (2020 - 2025)
Universe Pharmaceuticals' Debt to Equity history spans 6 years, with the latest figure at $0.04 for Q3 2025.
- On a quarterly basis, Debt to Equity fell 78.63% to $0.04 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.04, a 78.63% decrease, with the full-year FY2025 number at $0.04, down 78.63% from a year prior.
- Debt to Equity hit $0.04 in Q3 2025 for Universe Pharmaceuticals, down from $0.18 in the prior quarter.
- Over the last five years, Debt to Equity for UPC hit a ceiling of $0.28 in Q1 2024 and a floor of $0.0 in Q3 2022.
- Historically, Debt to Equity has averaged $0.08 across 5 years, with a median of $0.02 in 2021.
- Biggest five-year swings in Debt to Equity: plummeted 100.0% in 2021 and later surged 96748.37% in 2023.
- Tracing UPC's Debt to Equity over 5 years: stood at $0.0 in 2021, then tumbled by 77.21% to $0.0 in 2022, then soared by 104.93% to $0.0 in 2023, then soared by 89530.22% to $0.18 in 2024, then crashed by 78.63% to $0.04 in 2025.
- Business Quant data shows Debt to Equity for UPC at $0.04 in Q3 2025, $0.18 in Q3 2024, and $0.28 in Q1 2024.